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Abstract: Malaria modeling can inform policy and guide
research for malaria elimination and eradication from local
implementation to global policy. A research and devel-
opment agenda for malaria modeling is proposed, to
support operations and to enhance the broader eradica-
tion research agenda. Models are envisioned as an
integral part of research, planning, and evaluation, and
modelers should ideally be integrated into multidisciplin-
ary teams to update the models iteratively, communicate
their appropriate use, and serve the needs of other
research scientists, public health specialists, and govern-
ment officials. A competitive and collaborative framework
will result in policy recommendations from multiple,
independently derived models and model systems that
share harmonized database s .A sp l a n n e d ,m o d e l i n g
results will be produced in five priority areas: (1) strategic
planning to determine where and when resources should
be optimally allocated to achieve eradication; (2) man-
agement plans to minimize the evolution of drug and
pesticide resistance; (3) impact assessments of new and
needed tools to interrupt transmission; (4) technical
feasibility assessments to determine appropriate combi-
nations of tools, an associated set of target intervention
coverage levels, and the expected timelines for achieving
a set of goals in different socio-ecological settings and
different health systems; and (5) operational feasibility
assessments to weigh the economic costs, capital
investments, and human resource capacities required.
Introduction
A global malaria eradication effort will require massive changes
to a complex web of interconnected biological systems. The
optimal path to eradication is intrinsically unpredictable because
of the potential for parasites and vectors to evolve, the waxing and
waning of human immunity, and behavioural changes in human
and vector populations. The range of conditions that favour
malaria transmission are so varied and diverse that decisions and
plans cannot be based solely on the evidence that has been
acquired in randomized control trials conducted in only a few
settings. To succeed, eradication will require a strategic plan that is
constantly updated with the latest surveillance, monitoring, and
evaluation data. Moreover, planning processes involve some sort
of conceptual model, and this model will necessarily consider
many potential sources of uncertainty. Rational quantitative
mathematical models provide the best way to synthesize
information, quantify uncertainty, and extrapolate current knowl-
edge. Such models can provide critical quantitative insights that
are not otherwise possible.
The unique contributions that malaria modeling could
potentially make to research and policy for malaria eradication
led to the formation of a malERA Consultative Group on
modeling tasked with defining a research and development agenda
for modeling within a comprehensive malaria eradication research
agenda. Our discussion about the proper use of models focused on
balancing the need to provide robust policy recommendations
while maintaining the energy and creativity of competitive science.
The following document describes the history of malaria
modeling, discusses the framework we developed for reaching
consensus on the basis of independently derived models, provides
an agenda to improve the science of modeling with supporting
curated databases and digital interfaces, and identifies priority
tasks within the broader agenda.
Historical Background
Malaria transmission models originated with Ronald Ross
during a trip to organize malaria control in Mauritius (1907–1908)
[1], but the models of George Macdonald [2] were applied more
systematically during the Global Malaria Eradication Program
(GMEP) from 1955 to 1969 [3]. Macdonald emphasized the
importance of measuring quantities that were relevant for
eradication planning, such as the stability index (the expected
number of human bites by a mosquito over its lifetime) and the
basic reproduction ratio, R0 (the expected number of human cases
that would arise from each human case in a population with no
previous exposure to malaria and no malaria control) [4].
Mathematical analysis helped to explain why indoor residual
spraying with DDT was such a potent malaria control strategy [5].
Later, mathematical modeling played a key role in the design and
analysis of the Garki project in Nigeria [6], as well as the
introduction of new indices to measure transmission, including
vectorial capacity and the human blood index [7,8].
Despite its important contributions, the overall role of
mathematical modeling in the GMEP was limited. Modeling
informed the design of the ‘‘attack phase’’ of malaria eradication
[3], but not the design or implementation of other phases, and
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the GMEP despite its obvious limitations. For example, the Pare-
Taveta Malaria Scheme [9], which was implemented over 3.5
years in villages on the Tanzania-Kenya border, reduced malaria
prevalence to less than 5%. Without sustained investments,
however, malaria endemicity rebounded within 10 years of the
program ending. The lessons of this and other schemes were that
malaria control would require longer interventions and at a much
larger scale in the African context; the implications for the broader
program were never considered.
The GMEP also never considered what would happen if the
initial attack phase failed. Moreover, application of the modeling
was mainly limited to the Global Malaria Program in Geneva,
which was not considered to be an intrinsic part of the research
agenda for the GMEP. The failure to integrate and the neglect of
research were partly due an emphasis on streamlining GMEP’s
operations and contributed to a ‘‘one-size-fits-all’’ mentality, with
programmatic criteria based on early successes in Europe.
Despite having identified DDT resistance in Anopheles sacharovi
in 1951 [10], the only GMEP plans for dealing with resistance
were to have a highly focused and time-limited program. By
1964, the GMEP had reached only approximately 3.3% of the
malarious area in Africa, and the efforts were mainly concen-
trated at the margins of the continent [11]. After a WHO
meeting in Brazzaville in 1972, formal plans for dealing with
malaria in many African settings were devised [12] in which
malaria elimination was not considered to be feasible, and
‘‘control’’ was presented as an alternative and defined as
reduction of malaria to a point where it was no longer a major
public health threat. A final failure of the GMEP was in not
providing guidelines for establishing quantitative and operation-
ally meaningful definitions and milestones for measuring progress
towards control in a range of contexts.
The failure of the GMEP was due to many factors, including the
collapse of funding [13]. However, better research with built-in
monitoring, surveillance, and evaluation would have contributed
to the long-term prospects for the success of the GMEP, and
within that research-oriented framework, mathematical modeling
could have played a pivotal role. Insufficient use of modeling was
not the reason why the GMEP failed, but it could have played a
stronger role in helping to anticipate, analyze, and adjust to some
of the other problems that developed, such as the evolution of
insecticide resistance.
Since the GMEP, substantial advances have been made in the
theory and simulation modeling of malaria transmission (see Text
S1), but the main research challenge for malaria eradication will
be to integrate these models with surveillance, monitoring,
evaluation, and with the revision of national and regional plans
through every phase of eradication.
A Consultative Framework for Malaria Modeling
After reviewing the role of malaria modeling in past control and
eradication programs, the Consultative Group on modeling
discussed the best way of organizing modelers and modeling. A
consensus emerged that a unified approach aimed at developing
an all-encompassing model for malaria elimination or eradication
would probably repeat the mistakes of the past, and would
therefore be inadequate. Instead, we agreed that accomplishing
the modeling research agenda for eradication, avoiding errors, and
providing robust advice for the future would require a framework
that facilitates competitive and collaborative interactions and
active communication between modelers and other scientists,
research activities, surveillance, monitoring and evaluation, and
that is based on a shared set of data resources.
We therefore established and endorsed a framework, motivated
by climate modeling under the Intergovernmental Panelon Climate
Change, which is both collaborative and competitive (Figure 1). In
this framework, the core modeling functions would be conducted by
independent teams, working in isolation and then coming together
to compare and harmonize their results. The teams would compete
with one another to provide answers to questions, and yet they
would be cooperatively engaged in the common goal of finding the
best solution to a defined set of problems. An added advantage of
this approach, which builds on and formalizes the successful way in
which scientific research ordinarily takes place, is a rapid critique
from other competent modeling teams that limits the excesses of
particular models or modelers and emphasizes the limitations of
each approach and of models overall.
Two important features of this framework are the interface
between modelers and the users, and the development of curated
databases that are shared among all modelers. The Consultative
Group felt that direct contact between modelers and users was the
best way for modelers to be aware of the needs of their users, to be
aware of new developments and data, and for modelers to
communicate the limitations of their models. However, some
information could be usefully shared through digital interfaces.
The Consultative Group also recognized that the needs of the
users would evolve over time, and that the models must be
iteratively updated (the dashed arrows in Figure 1). It also
regarded databases and digital interfaces as essential to the
development of modeling and prioritized them as part of the
research and development agenda for modeling.
Importantly, because this type of framework has not been part
of the culture of malaria modeling, one of the first tasks of the
modeling research and development agenda will be to operatio-
nalize the framework in Figure 1, and formally establish a process
for consultations on relevant policy matters.
The Potential Role of Modeling: Strategic
Planning and Technical Feasibility Assessment
Malaria modeling should be used to inform strategic planning and
malariaeliminationassessmentsatarangeofscalesfromglobalpolicy
to local-level planning, and in guiding malaria control whether or not
such activities are considered the first step towards malaria
elimination. Strategic planning involves the assessment of where
Summary Points
N Mathematical modeling can guide all stages of malaria
elimination and eradication by synthesizing information,
quantifying uncertainty, and extrapolating current
knowledge
N Modelers and users/stakeholders need to work closely
with each other to ensure that models meet user needs
and end users understand the current limitations of
malaria transmission models
N A framework for modeling is being established that is
both collaborative and competitive
N Models must be closely tied to all the available data, and
databases and model outputs should be harmonized
N A single approach aiming at one, comprehensive model
for malaria elimination/eradication has limited value;
instead a variety of models and analytical approaches
should be employed to guide effectively elimination
efforts.
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eradication. Technical feasibility assessments define an appropriate
combination of tools, an associated set of target intervention coverage
levels, and the expected timelines for achieving reduction in burden,
transmission interruption, and finally malaria elimination. Models
can provide a rational and quantitative framework for integrating a
range of implementation strategies, including optimizing the mix of
interventions in a socio-ecological setting with different health systems
to achieve a set of goals leading to malaria elimination. These results
must be linked to operational assessments to describe the economic
costs, capital investments, and human resource capacities required
with explicit consideration of the long-term financing of malaria
control and elimination.
To be of greatest benefit, models developed for malaria
elimination support must specifically address changes in parasite,
human, and animal hosts, and vector populations across a range of
endemicities and health system conditions and capacities through
the different phases of a malaria elimination program. These phases
can be broadly categorized as: the initial planning phase (phase I);
the introductionof interventions to interrupttransmission leadingto
zero incidence (phase II, which corresponds to the Global Malaria
Action Plan [GMAP] ‘‘pre-elimination through elimination’’
phase); and ‘‘holding the line’’ (phase III or the GMAP ‘‘prevention
of re-introduction’’ phase). Each phase has different goals and
operational requirements, and will require different types of models.
For each phase, models can be used to optimize the sequence and
combinations of interventions, and for monitoring evaluation and
surveillance. Although economic models and behaviour and
malaria transmission models have been developed in isolation,
there is a great need for models that consider transmission within
economic models, and vice versa, for all phases of elimination.
Models can also be used to define and test phase-specific target
product profiles (TPPs) of new tools. TPPs describe the ideal,
desirable, or minimally sufficient properties of a new tool in
formalized documents that facilitate discussion between funding
agencies, product developers, and regulatory agencies. TPPs will
remain relevant throughout the path towards global eradication as
endemicity and health system requirements change, and as
countries adapt to their own unique challenges.
We anticipate that strategic planning will also need to account for
variationinthe mixofparasite speciesacrossthegeographicalrange
of malaria. At present, models are mainly focused on single-species
Plasmodium falciparum infections and require further development for
Plasmodium vivax, other parasite species, and mixtures of species.
Phase I: Planning
Planning involves a technical assessment to determine whether
elimination is feasible, based on the baseline distribution of
malaria and current tools, and on what level of intervention
coverage is required to reduce transmission intensity sufficiently to
achieve elimination. A key variable here is the basic reproduction
ratio R0. At a country level, it may not be possible to provide direct
estimates of R0. However, several measures related to transmission
intensity, including parasite prevalence, age-stratified seropreva-
lence, and entomological inoculation rate may be available.
Mathematical models are required to translate these measures into
Figure 1. A comprehensive framework for malaria modeling. Consultations will allow policy makers, research scientists, andother stakeholders
(U, users/stakeholders) from different country-specific health systems (HSM, country-specific health system models) to draw advice and analysis from
multiple, independently derived models (M) grounded on data collected (D, data bases) from research on vector ecology, malaria epidemiology, and
control through an interface that emphasizes direct engagement between modelers or modeling groups and end users. Image credit: Fusio ´n Creativa.
doi:10.1371/journal.pmed.1000403.g001
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would be a map of R0 at an appropriate spatial resolution.
The technical requirements for elimination are also directly
related to the operational and financial requirements for
elimination, so these must be linked in models to assessments of
health systems, economic costs and benefits of elimination, the
risks of failure, and the likely funding.
The second aspect of an initial feasibility assessment is to define
vulnerability, namely the risk that cases may be imported from
surrounding malaria-endemic countries. Direct measurement of
vulnerability is complicated in areas in which endemic transmission
is ongoing and will only be achievable when imported cases become
a substantial fraction of all cases. Preliminary assessments thus need
to be estimated indirectly by taking into account patterns of
endemicity in neighbouring countries and the level of cross-border
movements. Spatially stratified mathematical models can aid these
assessments, which are not considered in current strategic models.
Each country’s economic incentives to eliminate malaria may be
strongly influenced by the decisions of their neighbours. The
elimination of malaria from an entire region reduces the chances of
re-introducing malaria and is likely to create a regional public good,
which would make a strong economic case for coordinating
elimination campaigns among countries.
Modeling also has a key role to play in selecting appropriate
combinations of interventions to interrupt transmission and in
setting response timelines and expectations of impact. Models can
help to elucidate whether different interventions are likely to be
synergistic, and when they can be deployed to best effect.
Although insecticide-treated nets, indoor residual spraying, and
artemisinin combination therapies have been used successfully in
well-designed randomized control trials, these trials have been
conducted in a limited number of settings and the results of
applying the same control measures at the same intensity in
different places may vary depending on such factors as the
intensity and seasonality of transmission, the characteristics of the
parasites, and the immunological status of human populations.
There is no evidential basis for extending the results from existing
randomized control trials to the whole range of conditions that
exist in the real world and it is impossible to conduct randomized
control trials that cover all the factorial combinations of those
conditions. Using mathematical models, such experiments can be
simulated with minimal expense on a computer to obtain
immediate answers. Mathematical models are thus an indispens-
able tool for thinking carefully and quantitatively about the
dynamics of malaria control and elimination. Although computer-
based simulation studies are not a substitute for reality, they do
provide a highly refined and structured way of synthesizing
information and testing ideas. In particular, they provide a useful
tool for testing how differences in transmission can lead to different
results when the same interventions are applied in two different
populations.
Finally, drug and pesticide resistance were blamed for slow
progress during the GMEP and may have contributed to its failure
[11]. Malaria elimination and global eradication must therefore
anticipate that resistance will evolve and must incorporate this
inevitability into the plans. The functional significance of drug and
pesticide resistance on transmission has therefore been identified
as an important research topic for modeling to facilitate effective
strategic planning.
Phase II: Pre-elimination through Elimination
The context for transmission and the operational challenges
inevitably change as transmission is reduced to low levels. Previous
experience unambiguously demonstrates that low-level transmis-
sion presents protracted challenges that contribute to a loss of
commitment of countries and donors. In particular, the biology of
P. vivax poses unique challenges for malaria elimination during this
phase because of the dormant liver stages. Experience during the
previous malaria eradication campaign suggests that P. falciparum
will be eradicated long before P. vivax. The patterns of species
composition are therefore critical concerns for elimination, and
changes in the patterns can be used as a measure of progress
towards elimination of P. falciparum.
As exposure to malaria declines, malaria immunity begins to
wane, so each new case is more likely to result in clinical disease.
During these later phases, different strategies may be deployed to
shorten the response timelines, such as mass drug administration,
passive or active case detection, localized outbreak control, public
relations campaigns, prophylaxis for citizens traveling in malaria-
endemic areas, and possibly border controls. These strategies can
be supplemented by well-timed vector control. The optimal and
timely use of interventions may shorten the time until elimination
by decades.
Modeling can serve several roles in this phase. The first is to
help set expectations about the inevitable long response timelines,
since these will place increasing challenges on public health
officials to justify the expense. Setting unrealistic timelines can
undermine support for an elimination campaign and contribute to
failure.
As malaria becomes rare, the role of monitoring, evaluation,
and surveillance becomes critical [14]. Thus, a second role for
modeling is to help organize information about imported malaria,
to characterize transmission foci, and to design interventions.
Models can be used to simulate low-level transmission and control
and thus to help design and establish efficient sampling schemes
appropriate for the low and declining level of endemicity.
During this phase, new programmatic skills and capabilities
need to be developed that will prevent re-introduction or ‘‘hold the
line’’ in perpetuity. Modeling can help to establish the minimal
essential intervention coverage levels needed in this new
transmission setting, and models can help to fine tune the
programs to minimize both costs and the risk that malaria will re-
establish. Another important need at this stage will be to define
specific timelines and optimal strategies for P. vivax elimination.
As transmission becomes less intense, it also becomes more
sporadic and often highly focal. In many countries, a constant flow
of imported malaria can generate small clusters of ongoing
transmission without the re-establishment of endemic transmis-
sion. Consequently, this is likely to be a long phase for countries or
geographical areas close to malaria-endemic areas. Moreover, the
accomplishments of countries or geographical areas that have
eliminated their endemic reservoir and limited onward transmis-
sion but continue to have sporadic outbreaks may not be
recognized. Mathematical modeling can help to describe and
interpret the patterns of endemic, low-level onward transmission
or imported malaria, and provide important feedback to
monitoring and evaluation programs.
Phase III: Prevention of Reintroduction
Mathematical modeling has two essential purposes once local
elimination has been achieved. First, it can be used to assess the
sustainability of elimination in the local area or country. Second, it
provides a formal set of analytical tools to address the unique
challenges of keeping malaria out of countries that have
successfully eliminated the parasites.
After elimination, the basic approaches to holding the line are
broadly similar to the strategies towards the end of the program for
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to shift resources away from malaria control to other, more
pressing issues. Surveillance during this phase will remain critical,
especially to identify where and when malaria is imported. In these
circumstances, model development will play an important role in
improving the criteria for and the process of certifying malaria
elimination, and in determining when malaria elimination can be
scaled back without risking re-emergence of the parasite.
The sustainability of malaria elimination is related to several
factors. The evolution of drug and insecticide resistance, vaccine-
escape variants, human and vector behavioural changes, and other
kinds of ‘‘resistance’’ can threaten to undermine malaria
elimination programs at every phase. Similarly, volatility in
outside donor funding can threaten the viability of elimination
efforts and country-level motivation. Modeling provides a realistic
framework for setting donor expectations, as well as a way to
anticipate the problems that might arise. Models can also be used
to illustrate the consequences of stopping too early or failing to
finish the job. Endgame planning is an integral part of strategic
planning for regional elimination.
Research and Development Requirements for
Model Improvement
To best support the specific goals of malaria elimination, a
research and development agenda is required to improve
modeling. Several topics are currently in need of additional model
development and the acquisition of key pieces of evidence. Some
of these topics have only recently been identified by research,
others have not been addressed because they are considered to be
of limited interest.
Biology and Natural History
As the complex life cycle of malaria parasites becomes better
understood, new and improved models are needed to make use of
this information in elimination programs. First, better models of
the development of parasite species in their human and vector
hosts need to be devised and the features of the parasite life cycle
need to be quantified better. In particular, there is a need for
better data and models to quantify the importance of relapse in P.
vivax and the importance of other unique aspects of non-
falciparum parasites, and to quantify the nature of interactions
among all species [15].
Models are also needed to capture the human infectious
reservoir across a range of transmission intensities. Ill-understood
factors contribute to variability in the transition rates of parasites
from the asexual stage onwards and through each subsequent
stage of the transmission cycle in people and mosquitoes. Even if
for operational purposes, individuals with measurable parasites are
considered to be infected and therefore not distinguished from
gametocyte carriers, it remains important to capture the relative
infectiousness of different population groups in models.
The abiotic determinants of mosquito densities and the
dynamics of larval stages are poorly understood. Thus, there is a
need for models that consider the effects of, for instance,
seasonality and dry season refuges. Such models can provide
information about the potential of larval control and optimal larval
control strategies. The effects of infection and environment on
adult mosquito behaviour, infectivity, and survival also need to be
considered in modeling efforts [16].
The existence of natural immunity to malaria that partially
protects against disease or reduces transmission is a particularly
challenging problem for epidemiological models. The stimulation,
duration, and effects of acquired immunity need to be better
understood, and this understanding must be incorporated into
models to determine, for example, how many years of zero
transmission must pass before symptomatic disease can be used as
a marker of re-introduction [14,15].
Another aspect of parasite natural history that is not
comprehensively addressed in current malaria models is hetero-
geneity in hosts, parasites, and vectors. Substantive problems in
measuring levels of heterogeneity need to be addressed and these
effects need to be appropriately incorporated in models.
Heterogeneity is likely to have a greater impact on model results
as transmission is reduced.
Finally, as transmission is reduced, the effects of geographical
movement of the parasite that occur because of both vector and
human movements will dominate the dynamics. The relative role
of movement versus dry-season refuge in maintaining the
infectious reservoir in epidemic settings remains poorly understood
but will be a major determinant of the required control strategy to
achieve elimination and hold the line. Human movement in
particular is difficult to quantify on the basis of current data.
Spatially explicit models will need to be developed that can
adequately capture parasite movement and the linking of spatially
distinct populations [15].
Effects of Interventions
Models of the dynamics of drugs (pharmacokinetics and
pharmacodynamics [PK/PD], dosing regimens) and of vaccines
that interrupt transmission at various stages need to be developed.
In addition, there is a need to develop models that describe the
ecology of genetically modified mosquitoes and the potential
impact of such insects on malaria transmission [2,16].
The scope of models needs to be expanded to consider the
overall effects on and of health systems and to account for the
capabilities of preexisting health system infrastructures. Modeling
needs to include the effects of combinations of interventions/tools
and the effects of scheduling of interventions. It also needs to
support the optimization of TPPs and their alignment with the
existing packages of interventions. All these components need to
be supported by microeconomic appraisal [17].
Effects of Interventions on the Evolution of Resistance
Resistance to interventions is broadly defined to include any
heritable changes that reduce the effectiveness of drugs, pesticides,
vaccines, and other interventions. TPPs need to be considered
prospectively with model-based analyses of the likely evolution of
resistance. Modeling approaches need to be developed that
integrate population genetics and direct intervention effects, such
as PK/PD data for drug resistance, behavioural and physiological
changes in response to vector control, and molecular epidemiology
for vaccine escape variants. A critical feature for models is better
characterization of the biological cost of resistance. As new tools
are developed, it will be important to plan deployment strategies
with an awareness of the effects they will have on the evolution of
resistance [16,18,19].
Prerequisites for Achieving Modeling Objectives
To achieve these modeling objectives and to answer specific
research and operational questions, there is a need to create,
curate, and harmonize databases. An interface and a supporting
infrastructure (see Figure 1) must also be created to facilitate
combining databases and diverse datasets, including those that will
be generated by mathematical modeling. Importantly, as much
information as possible should be openly accessible from a single
place to facilitate modeling and the dissemination of model outputs
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Below we discuss the perquisites for achieving modeling objectives.
Compilation and Curation of Databases and
Harmonization of Model Outputs
The purpose of the databases will be to collect information for
various users in one place. For modelers, this information is
required to parameterize and validate malaria models, and to
extend them geographically and temporally. The malaria
community requires more general information for monitoring
and evaluating progress towards control/elimination/eradication.
A Web site that links to relevant information already on the Web,
that hosts databases and appropriate interfaces to databases that are
not hosted elsewhere, and that provides technologies that allow
other software applications to access the hosted information will
facilitate Web-based information exchange. Such a Web site would
also include automatically generated information summaries and
post synthetic data, data summaries, and summary statistics.
Data to be included on such a Web site should comprise, among
other things, disaggregated data on the natural history of different
human malaria species,disaggregatedmalariologicalfield data from
published and unpublished field research studies, data aggregations
from searches of published and unpublished literature, and data
from model outputs. The results of basic laboratory research, data
on nonhuman malarias, and genomic data should be excluded from
the early stages of the structure, however, except through hyperlinks
to major data repositories. There should be links to relevant
nonmalaria databases (e.g., UN demographic data, Demographic
and Health Surveys, climate, population, and remotely sensed
environmental data), but the platform should not host these
databases unless this is essential for the analysis of hosted core
data. Table 1 in Text S2 represents an initial list of the databases
that might be hosted or otherwise harmonized. The challenges and
requirements for achieving this are outlined below.
Primary Databases and Key Models
The potential database resources in Text S2 are necessarily
incomplete, but should be gradually extended and more effectively
interlinked. Different modeling approaches have common data
needs, many of which will be satisfied by the datasets listed in Text
S2. Spatially specific data will be required by some types of models
so many of these data need to be geolocated. An important subset
of data is the results of malariological field studies, especially field
trials of interventions; the results of observational studies (e.g., of
drug action) are also important. Parasitological data that are
specifically required include infectious durations and data from
field studies that can be used to estimate clearance rates. Specific
entomological data requirements include data on vector survival,
behaviour, and biting rates (including heterogeneity in biting
rates). There will be a need to include global databases of weather
and climate data, in particular temperature, rainfall, humidity, and
soil moisture. New databases will need to be developed to support
tracking of larval habitats and prediction of vector emergence
rates. Modeling will also need to be supported by access to human
demographic databases, including those of population distribution,
age structure, and migration rates. This information will require
access to data on transport networks (e.g., roads) and communi-
cations networks such as cell phones.
The compendium of resources detailed in Text S2 contains
information sources, at various levels of complexity and in various
states of assembly, that are of variable use to the modeling teams.
Text S1 describes the history of modeling and the range of models
currently available and under development.
Minimal Reporting Standards
Databases without descriptors are a static resource. A
traditional, if not widely used, way to audit data resources is to
describe them in a peer-reviewed article and append the
information as supplementary material. A new publication route
for data, such as an entirely new journal or a new article style in
existing journals, is perhaps required, with the intention of
encouraging the release of preexisting unpublished data while
solving the problem of suitable accreditation for data sources.
Data and Model Curation and Sustainability
The curation and improvement of large databases requires
significant personnel capacity for correction and assembly of new
information. Furthermore, this capacity needs to be sustained in the
long term for its value to remain and agreement has to be reached
on what constitutes acceptable information quality, how to define it,
and how to moderate correction. All stakeholders, not just
researchers, must be made aware of the limitations of models and
the data on which they rely. Data and model curation needs to be
inclusive while flagging and addressing known problems and using
disclaimers to avoid excessive reliance on questionable information.
Common Ontologies, Frameworks, and Metadata
Standards
An evolving way to audit database resources is to provide
machine-readable metadata so that third parties can employ Web
services to seamlessly harvest and/or integrate database informa-
tion in downstream applications. This harmonization process
requires that all databases be accessible to the extent that they can
be shared at the human and machine level with any third party
with as little administrative, technical, and logistical support as
possible. This prerequisite is rooted in the concept of the semantic
web, which provides the methods and technologies that allow
machines to understand, share, and reuse data in real time across
application, enterprise, and community boundaries. There will be
many benefits in investing in a semantic web, not least the
availability of resources that can be updated, minimizing human
errors in translation for third-party applications.
To formalize minimum standards in databases, an ontology is often
specified. An ontology is defined as relationships among a set of terms
in an agreed nomenclature that describe a database resource. There
are many examples of ontologies, all tailored to specific applications.
To develop an ontology for our specific purposes (if it were considered
valuable), the most relevant existing ones could be reviewed, a hybrid
ontology of useful descriptors constructed, and an expert group
established to fill the gaps. Ontologies are critical for translating
minimum reporting requirements into machine-readable metadata.
However, paradoxically, several metadata ‘‘standards’’ are under
development. Advice should be solicited from the information
technology community on which to adopt. Finally, candidate models
may require some minor modifications to their outputs for
harmonization with other similar models. This task could be done
by the original authors of the model or they could provide the
necessary information and a mandate for the modification to be
performed by the curators.
Incentives for Data Sharing
Proper incentives are required to guarantee that the data-sharing
tasks will be accomplished. Data provision and model integration
are challenging tasks that do not achieve immediate recognition but
facilitate exciting science and improve public health impact at some
future point. To implement semantic enrichments to databases and
make models more widely accessible will take time, thought, and
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new and also, importantly, valuable old datasets. This process will
require mechanisms for attribution, quality, and provenance
control, and long-term curation and hosting obligations. There is
a need to decide how resources will be partitioned between existing
databases and downstream resources/portals.
Open-access data sharing is a collective benefit that outweighs
individual concerns, even though most of the communities
gathering relevant data do not yet operate a culture of open
access. Accordingly, access to data needs to be negotiated
carefully, with the general philosophy being to minimize
restrictions and to gradually negotiate wider access for sensitive
datasets as questions of ownership and attribution are resolved.
Accessing Software-Engineering Skills
At present the level of interaction between end users of model
results and those developing and implementing the models is
relatively limited. The creation of interfaces that allow user access
depends on computer scientists and programmers and they must
work closely with domain experts to ensure that interfaces meet
the needs of all stakeholders. Most institutes carrying out malaria
research have only limited capacity to develop Web database
applications. Professional software teams with close links to
malariologists are needed to set up and maintain such a system.
Interface for Users and Stakeholders
There are a wide range of potential end users of mathematical
models and their outputs, including other researchers, funding
bodies, program implementers, planners, and policymakers. All of
these end users have different needs in regards to the models, and
there are many ways in which they could potentially interact with
them. The most common and effective interface is the modeler,
who will ideally be embedded in a research or policy-making
network with the research scientists, medical doctors, public health
officials, or policy makers who will be using the models. Such an
interface would facilitate active and direct communication about
models and outputs, alert modelers to the availability of new data,
and keep modelers current with a changing situation, which would
lead to iterative updating of models. Direct contact with modelers
can be supplemented in specific cases so that a researcher or
policymaker is able to interact directly with a computer to obtain
information ranging from specific queries about a predefined set of
scenarios to more sophisticated outputs using decision-support
systems. Regardless of the level of contact, it is important that
stakeholders are engaged throughout the model development
process so that model outputs and interfaces match user needs,
and end users understand the current limitations of transmission
models, in particular in terms of making quantitative predictions.
There is currently no readily available interface or ‘‘cyberin-
frastructure’’ that brings together data, models, and stakeholders
seamlessly at the required scale and scope, although prototype
systems are being tested. The description below outlines what is
feasible in the short term, assuming sufficient research and
development support. Text S3 provides a more detailed design.
Given a (possibly distributed) annotated database, a set of
software models with well-defined application programmer
Box 1. Research and Development Agenda for Modeling
Modeling approaches to guide elimination and
eradication
N To provide practical tools to help planners and policy-
makers assess the technical, operational, and financial
feasibility of malaria elimination.
N To assist in optimizing combined interventions for
elimination in different transmission and health systems
contexts.
N To assess and optimize TPPs for interventions and for
monitoring and evaluation, and to determine the potential
contribution of the products to the different phases of
malaria elimination.
N To ensure flexible management in choosing and designing
interventions, and for designing surveillance in collabora-
tion with monitoring and evaluation programs to identify
cost-effective strategies to shorten elimination timelines.
Further development of models and model systems
N Further basic modeling research is required on the within-
host dynamics of Plasmodium infections, the human
infectious reservoir, bionomics and ecology of the vectors,
dynamics of the stimulation and decay of human
immunity, heterogeneities in hosts, vector, and parasite
dynamics, and host and vector movements, to enable the
models to better answer strategic questions for malaria
elimination.
N Further development is required of models of drug
dynamics, vaccines that interrupt malaria transmission,
and the ecology of genetically modified mosquitoes.
Health system attributes need to be integrated into
current models for packages of interventions and linked
to microeconomic outputs.
N Models need to be further developed to consider the likely
development and impact of drug and pesticide resistance
at the various stages of elimination across different
transmission settings.
Enabling technologies
N Harmonization of databases and model outputs, which
entails:
# Identifying key data needs and deciding whether existing
information is of sufficient quality to inform the modeling.
# Identifying technologies that support machine-level ex-
change of malariometric data.
# Recognizing the importance of creating and maintaining
thoroughly annotated databases and models, along with
software tools and well-documented user interfaces with
close collaboration between software engineers and
malariologists to support model and data curation and
access.
N Development of cyberinfrastructures to generate and
execute efficient workflows for answering strategic ques-
tions. Cyberinfrastructures would identify and retrieve data
from distributed databases; identify and execute appro-
priate models, compose data, and model results across
multiple spatiotemporal scales and domains; and manage
information about provenance, citations, and assumptions.
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possible to develop a cyberinfrastructure that automates much of
the deductive reasoning required to answer common stakeholder-
specified questions. Models can be fitted into well-established
paradigms for data search and integration. The cyberinfrastruc-
ture would translate these questions into appropriate analyses on
the model output. Missing data inputs could be replaced by data
from other similar settings as extracted from the underlying
databases with the appropriate caveats made clear to the end user.
A question may trigger a cascade of data retrieval and model
execution, all managed by the cyberinfrastructure. If the available
data and models are insufficient to answer the question, the gaps
would be noted to assist in research program development. Output
of analyses performed by the structure would include a
comprehensive list of citations of the source materials. A list of
caveats to data inputs or model outputs (provided by the
stakeholders) on the scope of appropriate use would also be
included. The cyberinfrastructure therefore provides those con-
tributing data and developing models with an incentive to include
their information in the system with the assurance that results will
not be misinterpreted.
Conclusions
On the basis of our discussions, we propose a research and
development agenda for modeling that will effectively support
operations and important research questions in attempts to
achieve elimination and eradication of malaria and that lists the
prerequisites and research questions for the development of
modeling based on a comprehensive framework (Box 1). A single
approach aiming at one, comprehensive model for malaria
elimination/eradication has limited value. Rather, we will profit
at the operational level as well as at the scientific level from
answering the research questions and issues as outlined in this
paper using a variety of models and analytical techniques,
supported by direct interactions with modelers and common user
interfaces, and linked to curated essential databases.
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